Skip Navigation

Continuing Education in Anaesthesia, Critical Care & Pain 2008 8(3):95-99; doi:10.1093/bjaceaccp/mkn012
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME/CE:
Take the course for this article:
CEACCP, Volume 8 – Issue 3, June...
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Stanley, D.
Right arrow Articles by Tunnicliffe, W.
PubMed
Right arrow Articles by Stanley, D.
Right arrow Articles by Tunnicliffe, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia [2008]. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Management of life-threatening asthma in adults

David Stanley, MRCP FRCA and William Tunnicliffe, FRCP
Specialist Registrar in Anaesthesia and Intensive Care
Queen Elizabeth Hospital
Edgbaston
Birmingham B15 2TH
UK
Consultant in Respiratory and Intensive Care Medicine
Queen Elizabeth Hospital
Edgbaston
Birmingham B15 2TH
UK

Tel: +44 121 6271627 Fax: +44 121 6978291E-mail: bill.tunnicliffe@uhb.nhs.uk

Key Words: The primary pathophysiological problem in life-threatening asthma is expiratory gas-flow limitation. • Always be wary of normocapnia and consider it in clinical context; it may be a sign of patient deterioration or exhaustion. • Initiation of invasive ventilation is a clinical decision. • The safety of permissive hypercapnia is well established. Striving for normocapnia is likely to produce significant morbidity.

The first 150 words of the full text of this article appear below.

Asthma is a disease of predominantly reversible airway obstruction characterized by a triad of bronchial smooth muscle contraction, airway inflammation, and increased secretions; it is a major health problem for all age groups. For the majority, control of asthma symptoms is readily achieved; however, in a small minority, asthma may cause death. Although the mortality rate for asthma in those aged less than 65 yrs is now falling, there remain around 1400 asthma deaths in the UK each year (http://www.laia.ac.uk/kf_asthma_03.htm). Most of these occur in the pre-hospital setting and, in retrospect, the majority is considered potentially preventable. Factors associated with asthma death include disease severity, inadequate treatment, inadequate monitoring, the under use of written asthma management plans and adverse psychosocial and behavioural factors (www.sign.ac.uk/guidelines/fulltext/63/index.html).

Levels of severity of acute asthma exacerbations have been defined. The features of acute severe, life–threatening, and near fatal asthma are listed . . . [Full Text of this Article]


    Pathophysiology
 

    Management of life-threatening asthma
 
Initial management

Oxygen

Nebulized β2 agonists

Nebulized ipratropium bromide

Steroids

Intravenous magnesium sulphate

Intravenous bronchodilators

Epinephrine

Mechanical ventilation

Who should be intubated, and when and how should mechanical ventilation be initiated?

What are the initial goals of mechanical ventilation and how are they achieved?

Management of hypercarbia

Ongoing ventilatory management

Additional management methods

Inhalational anaesthetic agents

Extra-corporeal support

Bronchoscopy

Antibiotics

Non-Invasive ventilation

Heliox

Leukotriene antagonists

Monoclonal anti-IgE antibodies


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?